Healthlead PCL

Healthlead PCL Equity

The The Equity of Healthlead PCL (HL.BK) as of Nov 7, 2026 is 967.60 M THB. In the previous year, The Equity was 1.01 B THB — a change of -3.80% (lower).

Equity

967.60 MTHB

YoY

-3.80%

Last updated:

In 2025, Healthlead PCL's equity was 967.60 M THB, a -3.80% increase from the 1.01 B THB equity in the previous year.

The Healthlead PCL Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
86.33 M THB
Jan 1, 2019
108.09 M THB
Jan 1, 2020
124.97 M THB
Jan 1, 2021
865.89 M THB
Jan 1, 2022
941.99 M THB
Jan 1, 2023
968.05 M THB
Jan 1, 2024
1.01 B THB
Jan 1, 2025
967.60 M THB
The Healthlead PCL Equity history
YEAREquityYoY
967.60 MTHB-3.80%
1.01 BTHB+3.90%
968.05 MTHB+2.77%
941.99 MTHB+8.79%
865.89 MTHB+592.88%
124.97 MTHB+15.61%
108.09 MTHB+25.21%
86.33 MTHB+0.45%
85.94 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Healthlead PCL Stock analysis

What does Healthlead PCL do? Healthlead PCL operates pharmacies under four brands: Icare, Pharmax, vitaminclub, and Super Drug. The company distributes medicines, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and other health products through these branded outlets. It sells over 10,000 SKUs of healthcare items including medicines, supplements, and medical devices to meet diverse customer demands. The PRIME brand offers dietary supplements as part of its product portfolio. The company's revenue streams come from pharmacy sales across its four brand names and the distribution of healthcare products. Its subsidiaries handle the invention, development, importing, and distribution of medical supplies and health-related goods. Healthlead PCL targets retail consumers seeking healthcare products through its physical pharmacy locations and online services. The firm serves customers needing medicines, dietary supplements, medical equipment, and household healthcare items. Healthlead PCL's business model combines direct retail sales via its branded pharmacies with distribution of health products to various markets. The company focuses on offering a wide range of health-related products under its four pharmacy brands and the PRIME supplement line. Its operations include both the sale of products in-store and the distribution of goods to meet consumer needs for healthcare solutions. Healthlead PCL is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Healthlead PCL's Equity

Healthlead PCL's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Healthlead PCL's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Healthlead PCL's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Healthlead PCL's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Healthlead PCL’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Healthlead PCL stock

The Equity of Healthlead PCL is 967.60 M THB in 2025.

The Equity of Healthlead PCL changed from 1.01 B THB to 967.60 M THB, representing a -3.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Healthlead PCL since 2006 – with annual values, charts, and detailed analysis.

The Equity's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Healthlead PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Healthlead PCL

All Key Metrics — Healthlead PCL